464 related articles for article (PubMed ID: 33233762)
1. Interplay between Hepatitis D Virus and the Interferon Response.
Zhang Z; Urban S
Viruses; 2020 Nov; 12(11):. PubMed ID: 33233762
[TBL] [Abstract][Full Text] [Related]
2. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
Zhang Z; Urban S
J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
[TBL] [Abstract][Full Text] [Related]
3. Innate immune recognition and modulation in hepatitis D virus infection.
Jung S; Altstetter SM; Protzer U
World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes.
Zhang Z; Filzmayer C; Ni Y; Sültmann H; Mutz P; Hiet MS; Vondran FWR; Bartenschlager R; Urban S
J Hepatol; 2018 Jul; 69(1):25-35. PubMed ID: 29524530
[TBL] [Abstract][Full Text] [Related]
5. Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication.
Gillich N; Zhang Z; Binder M; Urban S; Bartenschlager R
J Hepatol; 2023 Jan; 78(1):78-89. PubMed ID: 36152765
[TBL] [Abstract][Full Text] [Related]
6. HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes.
Alfaiate D; Lucifora J; Abeywickrama-Samarakoon N; Michelet M; Testoni B; Cortay JC; Sureau C; Zoulim F; Dény P; Durantel D
Antiviral Res; 2016 Dec; 136():19-31. PubMed ID: 27771387
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread.
Zhang Z; Ni Y; Lempp FA; Walter L; Mutz P; Bartenschlager R; Urban S
J Hepatol; 2022 Oct; 77(4):957-966. PubMed ID: 35636579
[TBL] [Abstract][Full Text] [Related]
8. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.
Giersch K; Allweiss L; Volz T; Helbig M; Bierwolf J; Lohse AW; Pollok JM; Petersen J; Dandri M; Lütgehetmann M
J Hepatol; 2015 Aug; 63(2):346-53. PubMed ID: 25795587
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity.
Altstetter SM; Quitt O; Pinci F; Hornung V; Lucko AM; Wisskirchen K; Jung S; Protzer U
Cells; 2021 Nov; 10(11):. PubMed ID: 34831475
[TBL] [Abstract][Full Text] [Related]
11. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
He W; Ren B; Mao F; Jing Z; Li Y; Liu Y; Peng B; Yan H; Qi Y; Sun Y; Guo JT; Sui J; Wang F; Li W
PLoS Pathog; 2015 Apr; 11(4):e1004840. PubMed ID: 25902143
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.
Urban S; Neumann-Haefelin C; Lampertico P
Gut; 2021 Sep; 70(9):1782-1794. PubMed ID: 34103404
[TBL] [Abstract][Full Text] [Related]
14. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates.
Wang W; Lempp FA; Schlund F; Walter L; Decker CC; Zhang Z; Ni Y; Urban S
J Hepatol; 2021 Aug; 75(2):311-323. PubMed ID: 33845061
[TBL] [Abstract][Full Text] [Related]
15. The hepatitis delta virus: Replication and pathogenesis.
Sureau C; Negro F
J Hepatol; 2016 Apr; 64(1 Suppl):S102-S116. PubMed ID: 27084031
[TBL] [Abstract][Full Text] [Related]
16. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
17. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.
Lucifora J; Alfaiate D; Pons C; Michelet M; Ramirez R; Fusil F; Amirache F; Rossi A; Legrand AF; Charles E; Vegna S; Farhat R; Rivoire M; Passot G; Gadot N; Testoni B; Bach C; Baumert TF; Hyrina A; Beran RK; Zoulim F; Boonstra A; Büning H; Verrier ER; Cosset FL; Fletcher SP; Salvetti A; Durantel D
J Hepatol; 2023 May; 78(5):958-970. PubMed ID: 36702177
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes.
Tham CYL; Kah J; Tan AT; Volz T; Chia A; Giersch K; Ladiges Y; Loglio A; Borghi M; Sureau C; Lampertico P; Lütgehetmann M; Dandri M; Bertoletti A
Cell Rep Med; 2020 Jul; 1(4):100060. PubMed ID: 33205065
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis D virus infection, innate immune response and antiviral treatments in stem cell-derived hepatocytes.
Lange F; Garn J; Anagho HA; Vondran FWR; von Hahn T; Pietschmann T; Carpentier A
Liver Int; 2023 Oct; 43(10):2116-2129. PubMed ID: 37366005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
